Fycompa 2mg Tablet contains Perampanel, an antiepileptic medication used primarily to treat partial-onset seizures and primary generalized tonic-clonic seizures in patients with epilepsy. It works by selectively blocking AMPA receptors, which are involved in the excitatory neurotransmission in the brain, thereby reducing seizure activity. Fycompa is typically prescribed as an adjunctive therapy for individuals aged 12 years and older who have not achieved adequate seizure control with other antiepileptic drugs. The 2mg dosage allows for careful titration to minimize side effects while achieving therapeutic efficacy. Common side effects may include dizziness, somnolence, irritability, and headache, though more serious adverse effects such as behavioral changes or allergic reactions require immediate medical attention. Patients are advised to take Fycompa exactly as prescribed, usually once daily at bedtime, to maintain steady blood levels. It is important to inform healthcare providers of any other medications being taken, as Perampanel can interact with certain drugs, potentially altering its effectiveness or increasing side effects. Fycompa should not be discontinued abruptly to avoid the risk of increased seizures. Regular monitoring and follow-up with a healthcare professional are essential to optimize treatment outcomes and ensure patient safety.